Humana Inc. (HUM) SEC Filings & Earnings Calls

Minimum return protections for BlackRock create derivative liability exposure.

“CenterWell has also agreed to certain minimum return protections for BlackRock, resulting in the derivative instrument mentioned above.” · word for word

Potential changes to FY2026 GAAP EPS due to ongoing value creation and strategic initiatives.

“The Company does expect potential changes to its FY 2026 GAAP EPS guidance due to its ongoing value creation and other strategic initiatives including the significant reduction in liabilities related to the removal of the put option related to the existing WCAS joint ventures.” · word for word

One-time nature of Stars outperformance may not recur; competitive dynamics and regulatory changes could impact future benefits.

“the Company anticipates some of the outperformance in BY28 relative to Top Quartile will be one time in nature” · word for word

Medicare Advantage Star Ratings uncertainty for 2027 (Bonus Year 2028) pending CMS release in October.

“Company will not be commenting on 2027 Medicare Advantage (MA) Star Ratings (Bonus Year 2028) until the Centers for Medicare and Medicaid Services (CMS) releases final 2027 MA Star Ratings data in October.” · word for word

Star Ratings headwind for Bonus Year 2026 expected to pressure adjusted EPS year-over-year.

“FY26 Adjusted EPS guidance anticipates a year-over-year decline as a result of the Star Ratings headwind for Bonus Year (BY) 2026, net of mitigation.”

GAAP EPS guidance revised downward significantly due to non-cash adjustments (put/call, value creation, impairment).

“GAAP EPS guidance revised to at least $6.52 from at least $8.36, driven by put/call valuation adjustments ($1.47), value creation initiatives ($1.27), and impairment charges ($0.17).”

Medicare Advantage Star Ratings headwind

“the BY 2026 Star Ratings revenue headwind” · word for word

Regulatory changes (IRA, Medicare funding)

“It is reasonably possible that these laws and regulations... may have a material adverse effect on our results of operations” · word for word

Creates direct financial obligations and potential mandatory exercise triggers, including net worth decline below $4.0B.

“The Company will be required to exercise each Issuance Right in full upon certain other events, including if the Company reasonably believes its consolidated net worth has fallen below $4.0 billion.”

Star Ratings Revenue Headwind

“The consolidated benefit ratio increased 240 basis points from 87.0% for the 2025 quarter to 89.4% for the 2026 quarter primarily reflecting the BY 2026 Star Ratings revenue headwind” · word for word

New Member Benefit Ratio Dilution

“the effect of the individual MA membership growth during the most recent AEP and OEP as the new members, on average, run at a higher benefit ratio as compared to retained members” · word for word

CenterWell Margin Pressure from v28 Risk Model

“The CenterWell segment operating cost ratio increased 340 basis points from 91.1% for the 2025 quarter to 94.5% for the 2026 quarter primarily reflecting the final year of the phase-in of the v28 risk model revision” · word for word

Adjusted EPS down 11% YoY; GAAP EPS guidance revised down to 'at least $8.36' from 'at least $8.89'

“while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89'” · word for word

No material risk; routine board governance change.

“Standard director election and compensation disclosure.”

Increased leverage with subordinated debt; interest rate risk from floating rate after 2031

“Subordinated Notes bear interest at an annual rate of 6.625% to, but excluding September 15, 2031, following which such rate will reset in successive five-year periods until maturity at a rate equal to Five-year U.S. Treasury Rate as of the Reset Interest Determination Date plus 2.891%” · word for word

Medicare Advantage Industry Volatility

“the Committee recognized that 2023 and 2024 were dynamic and challenging years for the Medicare Advantage industry, our company and our stakeholders, as we and industry peers found ourselves responding to significant and unanticipated increases in medical cost trends.” · word for word

Medical Cost Trend Exceeding Expectations

“we were ultimately unable to fully offset these trends as they continued to accelerate in the fourth quarter of 2023. That trend ultimately resulted in a reset of earnings expectations for the entire industry that continued into 2025.” · word for word

Share Price Underperformance

“The Committee also considered the Company’s share price performance throughout the year relative to the broader market, largely impacted by these external factors” · word for word

PSU Payout Risk from Low Relative TSR

“the Company’s rTSR ranking in the 7.3rd percentile of the comparator group” · word for word

Government revenue concentration risk

“During 2025, 83% of our total premiums and services revenue were derived from contracts with the federal government” · word for word

Medicare Advantage regulatory risk

“All material contracts between Humana and CMS relating to our Medicare Advantage products have been renewed for 2026, and all of our product offerings filed with CMS and going to market for 2026 have been approved.” · word for word

Florida concentration risk

“These Florida contracts accounted for premiums revenue of approximately $17.8 billion, which represented approximately 20% of our individual Medicare Advantage premiums revenue, or 14% of our consolidated premiums and services revenue for the year ended December 31, 2025.”

Medical cost trend risk

“Capitation expense under delegated arrangements for which we have a limited view of the underlying claims experience was approximately $3.7 billion, or 3.3%, of total benefits expense, for the year ended December 31, 2025.” · word for word

Star Ratings headwind significantly impacts FY2026 earnings guidance.

“FY 2026 projected guidance anticipates a year-over-year decline as a result of the Star Ratings headwind for Bonus Year 2026, net of mitigation.” · word for word

GAAP net loss in Q4 2025 due to impairment charges and other adjustments.

“4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96.” · word for word

Leadership transition risk in key insurance segment

“Retirement of Insurance Segment President; new appointments may cause short-term disruption”

Guidance reaffirmation reduces near-term earnings uncertainty, but GAAP EPS subject to change due to ongoing value creation initiatives.

“The Company does expect potential changes to its FY 2025 GAAP EPS guidance due to its ongoing value creation and other strategic initiatives.” · word for word

Medicare Advantage membership decline

“Individual Medicare Advantage membership decreased 421,900 members, or 7.5%, from September 30, 2024 to September 30, 2025, inclusive of the decision to exit certain unprofitable plans and counties” · word for word

IRA Part D seasonality and benefit ratio volatility

“the quarter comparison was negatively impacted in the 2025 quarter as a result of the change in Medicare Part D seasonality due to the IRA” · word for word

Value creation initiative execution risk

“we recorded charges, primarily in severance charges in connection with workforce optimization and external consulting spend, of $267 million and $320 million for the three and nine months ended September 30, 2025, respectively” · word for word

GAAP EPS guidance cut due to value creation initiatives and other charges.

“Humana revises its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) to 'approximately $12.26' from 'approximately $13.77'” · word for word

Higher benefit ratio and operating cost ratio pressure margins.

“Benefit ratio 91.1% vs 89.9% YoY; Operating cost ratio 12.6% vs 11.5% YoY”